GlassScriptPhysician profile
Neal Johnson
NPI 1881671451
$13,379.43
in general payments reported to CMS, 2019-2025
48 companies · $495 in 2025
The $495 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,378 · 2020: $2,878 · 2021: $3,175 · 2022: $2,339 · 2023: $115 · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $370 · Consulting Fee: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $370.00 |
| Consulting Fee | $240.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $3,187.19 | 2019-2022 | |
| Novo Nordisk INC | $2,226.17 | 2019-2022 | |
| Lilly USA, LLC | $944.45 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $674.44 | 2019-2022 | |
| Amarin Pharma, INC. | $629.26 | 2019-2021 | |
| Abbvie INC. | $556.76 | 2020-2022 | |
| Glaxosmithkline, LLC. | $542.46 | 2019-2022 | |
| Radius Health, INC. | $504.63 | 2019-2022 | |
| Gilead Sciences, INC. | $426.76 | 2019-2022 | |
| Sekisui Diagnostics LLC | $370.00 | 2023-2025 | |
| Allergan, INC. | $342.56 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $335.57 | 2019-2022 | |
| Zoll Medical Corporation | $240.00 | 2025 | Defibrillator |
| Amgen INC. | $233.42 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $228.15 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neal Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.